BIOCRYST PHARMACEUTICALS INC short interest in 2026

In 2026, BIOCRYST PHARMACEUTICALS INC's disclosed short interest ran from 20.52% of shares outstanding on 15 Jan 2026 to 13.65% on 15 Sep 2026, a change of -6.87 percentage points. The year's high was 20.52% on 15 Jan 2026 and its low 12.28% on 15 Jul 2026, averaging 16.11% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.44 days on 31 Aug 2026. Full history: BIOCRYST PHARMACEUTICALS INC.

Cite this page

Plain

Short position data for BIOCRYST PHARMACEUTICALS INC short interest in 2026: FINRA, compiled by howshorted.com, settlement date 15 Sep 2026. https://howshorted.com/us/company/bcrx/2026/

Wikipedia

<ref>{{cite web |title=BIOCRYST PHARMACEUTICALS INC short interest in 2026 short position data |url=https://howshorted.com/us/company/bcrx/2026/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2026-09-15 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-biocryst-pharmaceuticals-inc-short-inter-2026-09-15,
  title        = {BIOCRYST PHARMACEUTICALS INC short interest in 2026 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/bcrx/2026/}},
  note         = {Data: FINRA, settlement date 15 Sep 2026; accessed 2026-10-13},
  year         = {2026}
}

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

2026 in figures

Start of year: 20.52% (15 Jan 2026)
End of year: 13.65% (15 Sep 2026)
Change: -6.87 pp
High: 20.52% (15 Jan 2026)
Low: 12.28% (15 Jul 2026)
Average: 16.11%
Highest days to cover: 14.44 (31 Aug 2026)
SEC filings marked: 7

Every report in 2026

BIOCRYST PHARMACEUTICALS INC short interest in 2026
Settlement	Short interest	Days to cover	Filings since previous
15 Jan 2026	20.52%	8.35	results (8-K)
30 Jan 2026	18.74%	8.51
13 Feb 2026	19.15%	10.04
27 Feb 2026	19.20%	8.69	10-K filed, results (8-K)
13 Mar 2026	17.80%	7.66
31 Mar 2026	16.72%	4.24
15 Apr 2026	18.30%	8.02
30 Apr 2026	14.72%	11.11
15 May 2026	14.21%	6.09	10-Q filed, results (8-K)
29 May 2026	14.42%	9.36
15 Jun 2026	15.99%	11.39
30 Jun 2026	19.16%	5.99
15 Jul 2026	12.28%	5.95
31 Jul 2026	12.84%	12.43
14 Aug 2026	12.89%	7.97	10-Q filed, results (8-K)
31 Aug 2026	13.33%	14.44
15 Sep 2026	13.65%	7.29

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.